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Abstract
Changes in brain structure and cortical function are associated with many chronic pain conditions including low back pain
and fibromyalgia. The magnitude of these changes correlates with the duration and/or the intensity of chronic pain. Most
studies report changes in common areas involved in pain modulation, including the prefrontal cortex (PFC), and pain-
related pathological changes in the PFC can be reversed with effective treatment. While the mechanisms underlying these
changes are unknown, they must be dynamically regulated. Epigenetic modulation of gene expression in response to
experience and environment is reversible and dynamic. Epigenetic modulation by DNA methylation is associated with
abnormal behavior and pathological gene expression in the central nervous system. DNA methylation might also be
involved in mediating the pathologies associated with chronic pain in the brain. We therefore tested a) whether alterations
in DNA methylation are found in the brain long after chronic neuropathic pain is induced in the periphery using the spared
nerve injury modal and b) whether these injury-associated changes are reversible by interventions that reverse the
pathologies associated with chronic pain. Six months following peripheral nerve injury, abnormal sensory thresholds and
increased anxiety were accompanied by decreased global methylation in the PFC and the amygdala but not in the visual
cortex or the thalamus. Environmental enrichment attenuated nerve injury-induced hypersensitivity and reversed the
changes in global PFC methylation. Furthermore, global PFC methylation correlated with mechanical and thermal sensitivity
in neuropathic mice. In summary, induction of chronic pain by peripheral nerve injury is associated with epigenetic changes
in the brain. These changes are detected long after the original injury, at a long distance from the site of injury and are
reversible with environmental manipulation. Changes in brain structure and cortical function that are associated with
chronic pain conditions may therefore be mediated by epigenetic mechanisms.
Citation: Tajerian M, Alvarado S, Millecamps M, Vachon P, Crosby C, et al. (2013) Peripheral Nerve Injury Is Associated with Chronic, Reversible Changes in Global
DNA Methylation in the Mouse Prefrontal Cortex. PLoS ONE 8(1): e55259. doi:10.1371/journal.pone.0055259
Editor: Bradley Taylor, University of Kentucky Medical Center, United States of America
Received September 7, 2012; Accepted December 20, 2012; Published January 28, 2013
Copyright:  2013 Tajerian et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding was received by Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca) MOP-102586 to L.S.S., MOP-42411 to M.S., and a grant
from Eli Lilly Canada Inc to M.C.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors wish to declare that this study was funded, in part, from a commercial funder (Eli Lilly Canada Inc). The funding was in the
form of an unrestricted research grant and the funder has no influence on the content. This does not alter the authors’ adherence to all the PLOS ONE policies on
sharing data and materials. The authors have declared that no competing interests exist.
* E-mail: moshe.szyf@mcgill.ca (MS); laura.s.stone@mcgill.ca (LS)
. These authors contributed equally to this work.
Introduction
Chronic pain is associated with changes in brain structure and
function. Multiple studies have now reported decreased brain grey
matter and abnormal cortical function associated with chronic
pain, and the magnitude of these changes may be related to the
duration and the intensity of chronic pain. While changes in some
brain regions are associated with specific pain conditions, many
studies report changes in common areas involved in pain
modulation, including the prefrontal cortex (PFC) (for reviews
see [1,2]. Interestingly, the PFC has also been implicated in
depression and anxiety, both of which are co-morbid with chronic
pain.
Chronic pain induces and actively maintains pathological
changes in the PFC: The induction of nerve injury in normal
rats results in the development of hypersensitivity to sensory
stimuli and in decreased grey matter in the PFC several months
post-injury [3]. Furthermore, reducing chronic pain in humans
reverses pain-related changes in PFC structure and function [4,5].
However, the mechanisms underlying chronic pain-induced
neuroplasticity are currently not understood.
Epigenetic modulation of gene expression in response to
experience and environmental changes is both dynamic and
reversible. Covalent modification of DNA by methylation is a
critical epigenetic mechanism resulting in altered gene expression.
The recognition of the role of DNA methylation in human disease
started in oncology but now extents to other disciplines including
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neurological disorders, and modulation by DNA methylation is
associated with abnormal behavior and pathological gene expres-
sion in the central nervous system (CNS). For example, adverse
environments early in life result in stable pathological changes in
methylation and gene function in the adult [6,7,8,9,10] that are
reversible with epigenetic drugs [11,12]. A plausible working
hypothesis is that long-term changes in DNA methylation in the
brain embed signals from transient injury or other exposures to
alter genome function in the brain, resulting in either the
chronification of pain or contributing to the co-morbid pathologies
associated with chronic pain. If this hypothesis is correct, then
DNA methylation changes in the brain should be detectable long
after exposure to the initial peripheral injury that triggered the
chronic pain.
The objectives of the current study were a) to determine if a
peripheral nerve injury that triggers long-term, persistent behav-
ioural signs of neuropathic pain and a decrease in grey matter in
the PFC several months post-injury [4] also triggers region-specific
changes in DNA methylation in the brain that can be detected
long after the initial injury and b) to determine whether these
changes are sensitive to an environmental manipulation that
attenuates pain. The primary findings are a) 5–6 months following
peripheral nerve injury, alterations in global DNA methylation are
observed in the PFC and amydala but not in the visual cortex or
thalamus, b) environmental enrichment reduces both behavioural
signs of neuropathic pain and pathological changes in PFC global
methylation, and c) PFC global methylation significantly correlates
with the severity of mechanical and cold sensitivity. Long-term
alterations in DNA methylation could therefore provide a
molecular substrate for chronic pain-related alterations in the




Two cohorts of 8–10 week-old male CD1 mice (Charles River,
St-Constant, QC, Canada) were used. Animals were housed in
ventilated polycarbonate cages and received water and rodent diet
(Teklad Rodent Diet 2020X) ad libitum.
Animals in the standard environment (Figures 1&2) were
housed in groups of 3–4 with a cardboard hut and cotton nesting
material. In contrast, the enriched environment consisted of three
mice/cage, a home cage running wheel mounted on a plastic hut
(Mouse IglooH with Fast-Trac running wheel, http://www.
bio-serv.com), and marbles. In the impoverished environment,
each animal was housed singly in an individual cage in the absence
of a running wheel, marbles or any other forms of enrichment. All
other factors including diet, bedding, access to water and light-
dark cycle were identical.
All experiments were approved by the Animal Care Committee
at McGill University, and conformed to the ethical guidelines of
the Canadian Council on Animal Care and the guidelines of the
Committee for Research and Ethical Issues of the International
Association for the Study of Pain published in PAIN, 16 (1983)
109–110. All surgery was performed under isoflurane anesthesia,
and all efforts were made to minimize suffering.
Induction of Nerve Injury
Neuropathy was induced using the spared nerve injury model.
Under deep anesthesia, an incision was made on the lateral surface
of the thigh through the muscle, exposing the three terminal
branches of the sciatic nerve: the sural, common peroneal and
tibial nerves. The common peroneal and the tibial nerves were
tightly ligated with 6.0 silk (Ethicon) and sectioned distal to the
ligation. The sural nerve was left intact. Sham surgery involved
exposing the nerve without damaging it [13].
Behavioral Assessment
All animals underwent baseline behavioral assessments imme-
diately prior to surgery and no differences were observed between
groups (data not shown). The first cohort were then re-assessed six
months following nerve injury or sham surgery control (Figures 1
and 2). In the environmental study (Figures 3 and 4), the presence
of nerve injury-induced hypersensitivity was confirmed three
months following surgery when the environmental manipulations
were implemented and again two months after environmental
change.
Mechanical Sensitivity. Calibrated monofilaments (Stoelt-
ing Co., Wood Dale, IL) were applied to the plantar surface of the
hindpaw and the 50% threshold to withdraw (grams) was
calculated as previously described [14]. The stimulus intensity
ranged from 0.008 g to 4 g.
Cold Sensitivity. A modified version of the acetone drop test
[15] was used: total duration of acetone-evoked behaviors
(flinching, licking or biting) was measured for 1 minute after
acetone (,25 ml) was applied to the plantar surface of the hindpaw
with the aid of a blunt needle attached to a syringe.
Motor Function. The accelerating rotarod assay was used
(IITC Life Science Inc., Woodland Hills, CA) with the mouse
adapter [16]. The task includes a speed ramp from 0 to 30 rpm
over 60 s, followed by an additional 240 s at the maximal speed.
Overall Activity. Mice were individually placed individually
into the centre of a transparent open field (26626 cm2) in a quiet
room illuminated with white light and their spontaneous behavior
was videotaped. The floor of the apparatus was equally divided
into nine squares. The total number of squares visited in a
5 minute period was assessed. An animal must fully enter the
square for it to be considered as visited. Since each square is
similar in size to an average mouse (,8–10 cm), the number of
squares visited serves as a proxy measure for general motor
activity.
Anxiety-like behavior. The same open field was used with
the primary measure being the time spent in the central square
during the 5 minute task [17].
Environmental Manipulation
Three months after injury or sham surgery, the presence of
neuropathic pain was confirmed and mice were randomly assigned
to one of four groups: injured with enriched environment, injured
with impoverished environment, sham with enriched environ-
ment, sham with impoverished environment. The standard,
enriched and impoverished environments are described above.
Mice were then re-tested 2 months following environmental
manipulation and tissue was collected.
Tissue Extraction
In the first study (Figures 1 and 2), animals were sacrificed 6
months after nerve injury or sham surgery by decapitation
following isoflurane anesthesia. In the enrichment experiment
(Figures 3 and 4), animals were sacrificed 5 months after nerve
injury or sham, of which the final 2 months were spent in enriched
or impoverished environments. Anatomical regions were defined
according to the stereotaxic coordinates (rostral–caudal, medial–
lateral and dorsal–ventral from bregma) by Paxinos and Franklin
[18]. The prefrontal cortex (right and left; +1 to +3, 21 to +1, 0 to
22.5), amygdala (right and left; 21 to 23, 64 to 61.5, 24 to
26), thalamus (0 to 23, 22 to + 2, 22.5 to 24.25), and visual
Changes in DNA Methylation following Nerve Injury
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cortex (right and left; 22 to 24, 23 to +3, 0 to 2) were extracted,
frozen on dry ice and stored at 280 C until use.
DNA Extraction
Tissue was homogenized and incubated in DNA extraction
buffer (500 ml) containing proteinase K (20 ml; 20 mg/ml; Roche,
Basel, Switzerland) at 50uC for 12 h. Samples were treated with
RNAase A (50 U/mg; 30 min; Roche) and phenol: chloroform
(1:1) added. After phase separation, ethanol (95%) was added to
precipitate the DNA. The DNA pellet was then washed and
redissolved in ddH2O.
Luminometric Methylation Assay (LUMA)
LUMA is a high throughput assay used to determine genomic
global DNA methylation. The LUMA method used in our study is
a modification described by Karimi et al. [19,20]. LUMA involves
the digestion of genomic DNA by methylation sensitive (HPAII) or
insensitive (MSPI) restriction enzymes in combination with an
internal control restriction enzyme (EcoRI) to normalize the DNA
input. Both HpaII and MspI restriction enzymes recognize and
cleave 59-CCGG-39 sequences producing 59-CG overhangs,
whereas EcoRI recognizes and cleaves 59-GAATTC-39 sequences
and produces 59-AATT overhangs. The extent of cleavage is
determined by a bioluminetric polymerase extension assay based
on a four-step pyrosequencing reaction.
Samples were incubated (37uC, 4 h) and then heat inactivated
(80uC, 20 min). Digested genomic DNA (15 ml) was mixed with
pyrosequencing annealing buffer (15 ml; Qiagen, Toronto, ON,
Canada). Samples were transferred to 24-well pyrosequencing
plates for sequencing (PyroMark 24; Biotage, Uppsala, Sweden).
The nucleotide dispensation order used was based on Pilsner et al.
[21]. Peak heights for C and A represent the HpaII and MspI cuts
(methylation) and EcoRI (input DNA), respectively. The formula
to calculate % genomic methylation is: 1-[(HpaII (C)/EcoRI (A)/
MspI (C)/EcoRI (A)]6100. All samples were run in triplicate.
Statistical Analysis
All data are expressed as mean 6 standard error of the mean
(SEM). Comparisons between injured and control groups
(Figures 1 and 2) or between enriched vs. impoverished
(Figures 3A,B) were performed using 2-tailed, unpaired student’s
t-test. The data in Figure 3C was analyzed by one-way ANOVA
followed by Tukeys test for multiple comparisons. Significance was
set at P,0.05. Welch’s correction was used when the assumption
of equal variances was not met. The degree of co-variation
between mechanical or cold sensitivity and global methylation was
determined by calculating Pearson’s coefficient since our data
followed a Gaussian distribution. Statistical analysis was under-
taken using Prism (GraphPad Software Inc, San Diego, Califor-
nia).
Figure 1. Behavioral Signs of Neuropathic Pain Six Months following Nerve Injury. Nerve injured mice show a decrease in mechanical
thresholds (A) and an increase in acetone-evoked behaviors, indicative of cold sensitivity (B) on the hindpaw, measured by the von Frey filament test
and the acetone tests, respectively. In addition, these mice show signs of motor dysfunction, measured by the rotarod assay (C). In the open field
assay (D), neuropathic mice do not differ from control mice in overall levels of spontaneous activity, measured by the number of peripheral squares
covered in the open field (e). However, they spent less time spent in the central square of the open field, indicative of anxiety-like behavior (f).
* = p,0.05, *** = p,0.0001, n = 10/group, error bars indicate S.E.M.
doi:10.1371/journal.pone.0055259.g001
Changes in DNA Methylation following Nerve Injury
PLOS ONE | www.plosone.org 3 January 2013 | Volume 8 | Issue 1 | e55259
Results
Behavioral signs of neuropathic pain, motor impairment
and anxiety six months following peripheral nerve injury
Chronic, persistent changes in cutaneous sensitivity to both
mechanical and cold stimuli were detected six months following
nerve injury. Injured mice displayed decreased mechanical
thresholds (Figure 1A) and increased acetone-evoked behaviors
(Figure 1B). Animals with nerve injury were significantly
impaired in motor capacity in the rotarod assay (Figure 1C).
Animals with neuropathy exhibited signs of anxiety in the open
field assay six months after injury (Figure 1D). Despite the fact
that injured animals visited the same number of peripheral squares
as control animals (Figure 1E), they spent significantly less time in
the central square compared to control mice (Figure 1F).
Nerve injury was associated with decreased global
methylation in the prefrontal cortex and amygdala, but
not the thalamus or visual cortex, six months following
injury
Peripheral nerve injury resulted in a decrease in global
methylation in the prefrontal cortex (Figure 2A) and the
amygdala (Figure 2B) that was detected 6 months after injury.
No significant changes were observed in the thalamus (Figure 2C)
or visual cortex (Figure 2D). Since there were no significant
differences in global methylation between right and left brain
structures, the results reported here are the average of the two
sides.
Environmental enrichment reverses nerve injury-induced
chronic pain and abnormal global methylation in the
prefrontal cortex
Three months after peripheral nerve injury, a second set of mice
were removed from standard housing and placed in either an
enriched or an impoverished environment for two additional
months. The enriched environment was associated with decreased
nerve injury-induced hypersensitivity to mechanical and cold
stimuli compared to the impoverished environment
(Figures 3A,B). This was accompanied by the recovery of nerve
injury-induced reductions in global methylation in the PFC to
normal, control levels (Figure 3C).
Correlation between global methylation in the prefrontal
cortex and hypersensitivity to cutaneous stimuli
Analysis of the data from Figure 3 revealed significant
correlations between the magnitude of both mechanical
(Figure 4A) and cold (Figure 4B) hypersensitivity and global
methylation in the PFC in injured, but not in control animals.
Specifically, following environmental manipulation, nerve-injured
animals with higher global % methylation in the PFC had reduced
hypersensitivity to mechanical and thermal stimuli.
Figure 2. Global Methylation in the CNS Six Months following
Nerve Injury. Nerve injured mice show a decrease in global
methylation in the PFC (a) and amygdala (b) six months after the
induction of peripheral neuropathy. No such changes were observed in
the thalamus (c) or visual cortex (d). *** = p,0.0001, n = 8–10/group,
error bars indicate S.E.M.
doi:10.1371/journal.pone.0055259.g002
Figure 3. Environmental Enrichment Reverses Nerve Injury-Induced Neuropathic Pain and Pathological Changes in DNA
Methylation in the Prefrontal Cortex. Three months following nerve injury and the establishment of chronic neuropathic pain, mice were
subjected to an enriched or an impoverished environment for an additional two months. Environmental enrichment resulted in decreases in
mechanical (A) and cold sensitivity (B) in nerve-injured animals towards control values. (C) These changes in cutaneous hypersensitivity following
environmental enrichment were accompanied by reversal of the nerve injury-induced decreases in global methylation in the impoverished group
such that global methylation was no longer different from control values (1-way ANOVA, F(3,21) = 4.545, p = 0.013, tukeys multiple comparison test).
* = p,0.05, ** = p,0.01,*** = p,0.001; control, enriched vs. impoverished or injured, enriched vs. impoverished; n = 5–8/group, error bars indicate
S.E.M.
doi:10.1371/journal.pone.0055259.g003
Changes in DNA Methylation following Nerve Injury
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Discussion
DNA Methylation and Chronic Neuropathic Pain
Epigenetic mechanisms triggered by injury have been hypoth-
esized to participate in mediating the lasting changes in the CNS
associated with chronic pain [22]. To date, most of the work
related to chronic pain has focused on the role of histone
acetylation/deacetylation [23], mainly using pharmacological
tools [24,25,26,27], with few reports of changes in DNA
methylation in chronic pain conditions [28,29,30,31]. In this
study, a mouse model of neuropathic pain following peripheral
nerve injury was used to test the hypothesis that ongoing, chronic
painful neuropathy induces changes in global DNA methylation in
the brain.
Our data show decreases in global DNA methylation in the
PFC and amygdala six months following a peripheral nerve injury
in the hindlimb. This is consistent with many of the comorbidities
that develop when pain has transitioned from being acute to
chronic, such as chronic-pain associated depression [32]. Further-
more, these global changes were region-specific; similar effects
were not observed in the thalamus or the visual cortex, even
though the former receives direct input from nociceptive neurons.
It is important to note that regions that did not show global
changes may still undergo changes in DNA methylation at the
individual gene level that are not detectable by a global
methylation assay such as the LUMA. However, the fact that
alterations were observed in the PFC and amygdala shows a strong
link between nerve injury-induced hypersensitivity and changes in
DNA methylation in the brain and provides a potential link
between injury, chronic pain and co-morbidities such as cognitive
dysfunction, depression and anxiety.
The magnitude of the nerve injury-associated changes in global
methylation in the PFC from 60% to 48% suggests that the
changes are broad and affect wide parts of the genome. It is
estimated that the mouse genome contains ,20 million CpG sites,
the targets for DNA methylation. The LUMA assay used in this
study is sensitive to ,1.5 million of these sites. Therefore, a
decrease of 12% in this assay corresponds to a minimum estimated
demethylation of ,180,000 CpG sites following nerve injury, a
number predicted to alter the expression of hundreds of individual
genes [33].
Global methylation is an indicator of the overall state of the
DNA methylation machinery and has long-range consequences on
genome function and organization [34,35,36]. Recent data
suggests that the landscape of altered DNA methylation in other
pathologies such as cancer spans thousands of genes [37] and
intergenic regions [38]. Programming of DNA methylation
encompasses both global changes in genome methylation and
gene-specific changes that target discreet regulatory regions, thus
affecting gene expression. Changes in global DNA methylation
state affect high-level organization of genome function [39]. These
changes produce lasting effects on the regulation of the
transcriptome and higher order chromatin folding [40] and are
capable of affecting many aspects of cell function. The population
of methylated CpG sites in gene promoters and known regulatory
regions constitutes only a small fraction of global DNA methyl-
ation. Given the magnitude of the pathological changes in DNA
methylation observed in this study, they must therefore also
involve regions in the genome beyond individual gene promoters
and gene regulatory sequences. Indeed, demethylation/methyla-
tion of all known promoters and regulatory regions in the genome
would in itself not have a significant impact on global DNA
methylation.
Dynamic Mechanisms Mediating Chronic Pain
In this study, the epigenetic changes were attenuated by a
behavioral intervention. Environmental enrichment reversed
nerve injury-related reductions in global DNA methylation in
the PFC and reduced hypersensitivity to mechanical and cold
stimuli. Furthermore, the % global PFC methylation co-varied
with the severity of neuropathic pain. It is currently unclear why
similar correlations were not observed in the uninjured, control
mice. While it is also not clear whether it is the enrichment itself or
the pain attenuation that is mediating the reversal of hypo-
methylation in the PFC, data from the enrichment experiment
nonetheless suggests that the methylation changes in the brain are
dynamic and reversible by a behavioral intervention. Regardless,
the particularly relevant since, in human patients with low back
pain, both pain duration and intensity has been related to reduced
grey matter in the PFC [41], and the magnitude of pain reduction
following treatment correlated with corresponding increases in the
thickness and normalization of functional activity in the PFC [4].
Figure 4. Global Methylation in the Prefrontal Cortex Correlates with the Magnitude of Nerve Injury-Induced Hypersensitivity.
Correlation analysis was performed on the data from Figure 3. Significant correlations were observed between % global methylation and
hypersensitivity to mechanical (a) and cold stimuli (b), in neuropathic but not control mice. * = p,0.05, ** = p,0.01.
doi:10.1371/journal.pone.0055259.g004
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We therefore speculate that the regulation of global methylation
such as described here may contribute to the dynamic changes in
cortical structure and function observed in human chronic pain
patients.
Distance from the Time and Site of Injury
The main finding emphasized in this manuscript is the long-
range effects of peripheral nerve injury on the mouse methylome.
Equally interesting is the observation that these methylation
changes occur at a site distant from the original injury. While
epigenetic changes have been reported in the dorsal root ganglia
and spinal cord following persistent pain states [30,31], here we
focused on higher-order processing centers in the brain. Interest-
ingly, in the study by Wang et al., decreasing global DNA
methylation in the spinal cord resulted in attenuation of pain
symptoms in the first two weeks following chronic constriction of
the sciatic nerve in rats; this is the opposite of what we would
predict in the PFC [30]. Thus, the directionality and consequences
of changes in global DNA methylation in chronic pain may be
region-specific (spinal vs. supraspinal), species-specific (rat vs.
mouse), may vary by type of injury or may vary as a function of
chronicity (2 weeks vs. 6 months). Each of these possible
explanations has potential clinical implications, additional studies
are needed to further explore this discrepancy.
Pain is more than mere nociception; according to the
International Association for the Study of Pain (IASP), pain is
defined as ‘‘…an unpleasant sensory and emotional experience
associated with actual or potential tissue damage, or described in
terms of such damage’’ [42]. It is therefore crucial that we study
the effects of chronic pain in areas that are involved in perception
and emotional processing, such as the PFC and amygdala. Our
data draws attention to the nature of chronic pain as a complex
phenomenon: it is associated with higher order behavioral co-
morbidities beyond changes in nociceptive thresholds, and it
encompass a wide range of conditions that make chronic pain a
disease that is difficult to understand and to treat.
Limitations and Future Directions
The current data is consistent with the working hypothesis that
DNA methylation is involved in chronic pain: a peripheral injury
that leads to chronic pain triggers changes in global DNA
methylation. However, it does not define a causal relationship
between DNA methylation in the brain and chronic pain or its
associated pathologies nor does it establish a relationship between
these changes in DNA methylation and changes in gene
expression. Future studies could address the causal relationships
by evaluating the effects of pharmacological or environmental
modulation of DNA methylation on pain threshold.
Although our data shows that environmental enrichment
returned nerve injury-related changes in global DNA methylation
to control levels, it is possible that a certain populations of
individual gene promoters maintained their differentially methyl-
ated state. Future studies incorporating comprehensive, high
throughput analysis of changes in DNA methylation and their
effect on the expression of individual genes in chronic pain
conditions are needed. Such studies are currently underway in our
laboratory.
Our study does not distinguish between the effects of nerve
injury from those of ongoing chronic pain and its comorbidities. It
is possible that the observed supraspinal changes are due to other
effects of the nerve injury itself such as motor impairment instead
of being a consequence of living with chronic pain. Finally, the
current study does not examine the time-course of global
methylation changes, instead focusing on the long-term effects of
peripheral neuropathy on the brain. Further studies are needed to
determine how long after nerve injury changes in global DNA
methylation develop and if they contribute to or are the result of
pain chronification.
Our data is consistent with two alternative but not mutually
exclusive hypotheses regarding the involvement of DNA methyl-
ation in chronic pain. First, DNA methylation might mediate the
effects of peripheral nerve injury on chronic pain by altering
epigenetic programming in the brain and inducing the central
phenotypes associated with chronic pain. Second, chronic pain
might induce the DNA methylation changes, which in turn trigger
the downstream pathologies that accompany chronic pain. It is
also possible that DNA methylation is involved in both processes.
These questions need to be addressed in future studies. Under-
standing the mechanisms underlying the transition from transient
injury to chronic pain as well as the mechanisms mediating the
impact of chronic pain on mental and physical health are
questions of prime significance. Our study shows that DNA
methylation is a plausible mediator of these mechanisms.
Conclusions
Epigenetic modifications are at the interface between environ-
ment and genetics, creating a mechanism by which life experiences
lead to long-lasting changes in gene expression. Here we show that
the induction of peripheral nerve injury has an impact on the
brain in the form of decreased DNA methylation in the PFC and
amygdala 5–6 months following initial injury. In addition, these
pathological changes can be attenuated with environmental
enrichment, an intervention that ameliorates neuropathic pain in
these animals. Furthermore, global methylation in the PFC
correlates to symptom severity. Abnormal DNA methylation in
the PFC may therefore provide a molecular substrate for pain-
related dysfunction in brain structure and function. Targeting of
these changes represents a potential novel therapeutic strategy for
the treatment of chronic pain. The implications of epigenetic
involvement in chronic pain are wide reaching and may alter the
way we think about pain diagnosis, research and treatment.
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